Picture of Paxman AB (publ) logo

PAX Paxman AB (publ) Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1m-14.67%
3m-29.47%
6m-32.29%
1yr-23.7%
Volume Change (%)
10d/3m-35.36%
Price vs... (%)
52w High-35.9%
50d MA-11.09%
200d MA-22.8%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)14.81
PEG Ratio (f)0.19
EPS Growth (f)334.35%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value2.99
Price to Tang. Book5.61
Price to Free Cashflown/a
Price to Sales4.34
EV to EBITDA33.55

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital3.37%
Return on Equity1.7%
Operating Margin4.99%

Financial Summary

Year End 31st DecUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueSEKm78.0596.2145.92210.12253.01322.5465.524.3%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/a+382.55-62.5+389.24n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Paxman AB (publ) EPS forecast chart

Profile Summary

Paxman AB (publ) is a Sweden-based developer of scalp cooling technology. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The Company offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Company’s primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.

Directors

Last Annual
December 31st, 2024
Last Interim
September 30th, 2025
Incorporated
October 7th, 2016
Public Since
June 12th, 2017
No. of Employees
142
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
se flag iconOMX Nordic Exchange Stockholm
Shares in Issue
23,273,416

PAX Share Price Performance

Upcoming Events for PAX

Similar to PAX

Picture of Acarix AB logo

Acarix AB

se flag iconOMX Nordic Exchange Stockholm

Picture of AddLife AB logo

AddLife AB

se flag iconOMX Nordic Exchange Stockholm

Picture of ADDvise AB (publ) logo

ADDvise AB (publ)

se flag iconOMX Nordic Exchange Stockholm

Picture of ADDvise AB (publ) logo

ADDvise AB (publ)

se flag iconOMX Nordic Exchange Stockholm

Picture of Arcoma AB logo

Arcoma AB

se flag iconOMX Nordic Exchange Stockholm

FAQ